The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global single-use bioprocessing market reached a value of US$ 12.2 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 31.5 Billion by 2027, exhibiting a CAGR of 18.4% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Single-use bioprocessing, or disposables, consists of various pharmaceutical solutions and products that are designed to be used once and then discarded. Media bags, containers, filtration assemblies, single-use bioreactors, disposable mixers, tubes, connectors and samplers are some of the most commonly used single-use bioprocessing products. These products are often used in the production of monoclonal antibodies, vaccines, plant cell cultivation and specific cell therapies. They are also utilized by biopharmaceutical manufacturers and life science research organizations for increasing productivity and ease of disposal with minimal risk of cross-contamination.
The increasing demand for pharmaceutical products across the globe is one of the key factors driving the growth of the market. The single-use bioprocessing technology is commonly used in media preparation and shipping of biologics while manufacturing pharmaceuticals. Furthermore, there is a growing preference for single-use products manufactured using high-grade polymer materials and plastic composites as they offer enhanced integral strength and aid in reducing the overall operational costs. It also ensures continuity in biomanufacturing, which is further providing a boost to the market growth. Additionally, various technological advancements, including the utilization of automation, big data and machine learning (ML) solutions in bioprocessing, are creating a positive outlook for the market growth. Such technological solutions aid in developing analytical models for predicting errors and improving accuracy during medical procedures. Other factors, including significant developments in the healthcare sector and extensive research and development (R&D) activities, are projected to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global single-use bioprocessing market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type, application, end-use and end-user.
Breakup by Product Type:
Breakup by Application:
Breakup by End-Use:
Breakup by End-User:
Breakup by Region:
The report has also analysed the competitive landscape of the market with some of the key players being Applikon Biotechnology, Boehringer Ingelheim, Cesco Bioengineering Company, Corning Inc., Danaher Corporation, Entegris, Eppendorf AG, Finesse Solutions Inc., GE Healthcare, Infors, Merck Millipore, Rentschler Biotechnologie, Sartorius Stedim Biotech, Thermo Fisher Scientific, 3M Company, etc.
|Base Year of the Analysis||2021|
|Segment Coverage||Product Type, Application, End-Use, End-User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico, Argentina, Colombia, Chile, Peru, Turkey, Saudi Arabia, Iran, United Arab Emirates|
|Companies Covered||Applikon Biotechnology, Boehringer Ingelheim, Cesco Bioengineering Company, Corning Inc., Danaher Corporation, Entegris, Eppendorf AG, Finesse Solutions Inc., GE Healthcare, Infors, Merck Millipore, Rentschler Biotechnologie, Sartorius Stedim Biotech, Thermo Fisher Scientific and 3M Company|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at